Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.5M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
+9.04K
-
Total reported value, excl. options
-
$40.7M
-
Value change
-
-$957K
-
Number of buys
-
13
-
Number of sells
-
-8
-
Price
-
$4.05
Significant Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q1 2016
21 filings reported holding KURA - Kura Oncology, Inc. - Common Stock as of Q1 2016.
Kura Oncology, Inc. - Common Stock (KURA) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
of 87.5M outstanding shares and own 11.69% of the company stock.
Largest 10 shareholders include FMR LLC (3.1M shares), EcoR1 Capital, LLC (2.47M shares), Partner Fund Management, L.P. (1.54M shares), CLOUGH CAPITAL PARTNERS L P (1.07M shares), FRANKLIN RESOURCES INC (731K shares), Boxer Capital, LLC (646K shares), VANGUARD GROUP INC (294K shares), Monashee Investment Management LLC (175K shares), Birchview Capital, LP (79.1K shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (63K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.